Hypha Labs, Inc. Financial Summary

Quick Answer

Hypha Labs, Inc. reported Total Revenue of $2.70 million for fiscal year 2022.

Hypha Labs, Inc. — Key Financials by Year

Metric 2025 2024 2023 2022 2021 2020
Total Revenue $2.70M
+7.8%
$2.50M
-2.7%
$2.57M
+0.9%
Revenue (ASC 606) $2.70M
+7.8%
$2.50M
-2.7%
$2.57M
+0.9%
Net Income -$3.10M
-294.9%
-$785.4K
-418.3%
$246.8K
+112.0%
-$2.06M
-199.7%
-$686.5K
+70.3%
-$2.31M
-27.9%
Diluted EPS -$0.02
-100.0%
-$0.01 $0.00
+100.0%
-$0.03
Total Assets $409.2K
-17.1%
$493.8K
-65.0%
$1.41M
+5.2%
$1.34M
-29.0%
$1.89M
+5.6%
$1.79M
+31.9%
Cash and Equivalents $56.2K
-81.0%
$295.9K
+257.6%
$82.7K
-74.4%
Stockholders Equity -$2.44M
-93.3%
-$1.26M
+42.8%
-$2.21M
+19.6%
-$2.74M
-160.4%
-$1.05M
+3.3%
-$1.09M
-355.8%
R&D Expense
Operating Income -$3.00M
-64.3%
-$1.83M
-317.7%
-$437.4K
+62.0%
-$1.15M
-48.9%
-$772.4K
+64.8%
-$2.19M
-18.9%
Gross Profit $1.07M
+49.0%
$715.2K
-10.1%
$795.8K
-5.2%
Shares Outstanding 147.12M
+19.6%
123.05M
+41.3%
87.10M
+15.9%
75.15M
+5.5%
71.23M
+22.2%
58.27M
+20.5%

Most Recent Quarter

Metric Quarter Ending Value YoY QoQ
Total Revenue December 31, 2022 $726.8K +3.9% +6.5%
Revenue (ASC 606) December 31, 2022 $726.8K +3.9% +6.5%
Net Income December 31, 2025 -$521.6K +61.1% +7.2%
Diluted EPS December 31, 2025 $0.00 +100.0%
Total Assets December 31, 2025 $391.6K +51.4% -4.3%
Cash and Equivalents June 30, 2022 $225.2K +209.3% +172.1%
Stockholders Equity December 31, 2025 -$2.69M -71.6% -10.2%
R&D Expense June 30, 2015 $73.7K -44.0%
Operating Income December 31, 2025 -$475.0K +63.6% +11.4%
Gross Profit December 31, 2022 $303.9K +9.7% +13.2%
Shares Outstanding December 31, 2025 155.52M +22.9% +5.7%
  • Hypha Labs, Inc. reported Total Revenue of $2.70 million for fiscal year 2022.
  • Hypha Labs, Inc. showed an increase of +7.8% in Total Revenue compared to the prior fiscal year.
  • Hypha Labs, Inc. reported Revenue (ASC 606) of $2.70 million for fiscal year 2022.
  • Hypha Labs, Inc. showed an increase of +7.8% in Revenue (ASC 606) compared to the prior fiscal year.
  • Hypha Labs, Inc. reported Net Income of -$3.10 million for fiscal year 2025.
  • Hypha Labs, Inc. showed a decrease of -294.9% in Net Income compared to the prior fiscal year.
  • Hypha Labs, Inc. reported Diluted EPS of $0.02 per share (loss) for fiscal year 2025.
  • Hypha Labs, Inc. showed a decrease of -100.0% in Diluted EPS compared to the prior fiscal year.
  • Hypha Labs, Inc. reported Total Assets of $409.2 thousand for fiscal year 2025.
  • Hypha Labs, Inc. showed a decrease of -17.1% in Total Assets compared to the prior fiscal year.
  • Hypha Labs, Inc. reported Cash and Equivalents of $56.2 thousand for fiscal year 2022.
  • Hypha Labs, Inc. showed a decrease of -81.0% in Cash and Equivalents compared to the prior fiscal year.
  • Hypha Labs, Inc. reported Stockholders Equity of -$2.44 million for fiscal year 2025.
  • Hypha Labs, Inc. showed a decrease of -93.3% in Stockholders Equity compared to the prior fiscal year.
  • Hypha Labs, Inc. reported R&D Expense of $143.8 thousand for fiscal year 2015.
  • Hypha Labs, Inc. showed an increase of +521.7% in R&D Expense compared to the prior fiscal year.
  • Hypha Labs, Inc. reported Operating Income of -$3.00 million for fiscal year 2025.
  • Hypha Labs, Inc. showed a decrease of -64.3% in Operating Income compared to the prior fiscal year.
  • Hypha Labs, Inc. reported Gross Profit of $1.07 million for fiscal year 2022.
  • Hypha Labs, Inc. showed an increase of +49.0% in Gross Profit compared to the prior fiscal year.
  • Hypha Labs, Inc. reported Shares Outstanding of 147.12 million shares for fiscal year 2025.
  • Hypha Labs, Inc. showed an increase of +19.6% in Shares Outstanding compared to the prior fiscal year.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment